share_log

Avalo Therapeutics | 424B5: Prospectus

SEC announcement ·  Feb 4, 2020 16:46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more